3
Participants
Start Date
June 30, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
Obatoclax Mesylate
30 mg given by vein over 3 hours on Days 1-3 of each 14-day study cycle.
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Gemin X
INDUSTRY
M.D. Anderson Cancer Center
OTHER